Off-Label Uses of Dexmedetomidine

Advances in Anesthesia

Volumn 24, Issue , 2006, Pages 177-192

  Popat, Keyuri ^a   Purugganan, Ronaldo ^a   Malik, Imrana ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750513397     PISSN: 07376146     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.aan.2006.06.007     Document Type: Review

References (49)

1. Gertler R., Brown H.C., Mitchell D.H., et al. Dexmedetomidine: a novel sedative-analgesic agent. BUMC Proceedings 14 (2001) 13-21
2. Virtanen R., Sawvola J.M., Saano V., et al. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol 150 (1988) 9-14
3. Aho M., Lehtinen A.M., Erkola O., et al. The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isolflurane requirements in patients undergoing abdominal hysterectomy. Anesthesiology 74 (1991) 997-1002
4. Aantaa R., Kanto J., Scheinin M., et al. Dexmedetomidine, an alpha 2 adrenergic agonist, reduces anesthetic requirements for patients undergoing minor gynecological surgery. Anesthesiology 73 (1990) 230-235
5. Aho M., Scheinin M., Lehtinen A.M., et al. Intramuscularly administered dexmedetomidine attenuates hemodynamic and stress hormone responses to gynecologic laparoscopy. Anesth Analg 75 (1992) 932-939
6. Morgan M., Heinricher M., and Fields H. Circuitary linking opioid-sensitive nociceptive modulatory systems in periaque-ductal gray and spinal cord with rostral ventromedidal medulla. Neuroscience 47 (1992) 863-871
7. Belleville J.P., Ward D.S., Bloor B.C., et al. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology 77 (1992) 1125-1133
8. Khan Z.P., Munday I.T., Jones R.M., et al. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. I: Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth 83 (1999) 372-380
9. Fragen R., and Fitzgerald P. Effect of dexmedetomidine on the minimum alveolar concentration (MAC) of sevoflurane in adults age 55 to 70 years. J Clin Anesth 11 (1999) 466-470
10. Scheinin B., Lundgren L., Randell T., et al. Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and perioperative fentanyl. Br J Anaesth 68 (1992) 126-131
11. Dyck J., and Shafer S. Dexmedetomidine pharmacokinetics and pharmacodynamics. Anaesth Pharm Review 1 (1993) 238-245
12. Khan Z.P., Ferguson C.N., and Jones R.M. Alpha-2 and imidazoline receptor agonists: their pharmacology and therapeutic role. Anaesthesia 54 2 (1999) 146-165
13. Martin E., Ramay G., Mantz J., et al. The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med 18 1 (2003) 29-41
14. Venn R.M., Karol M.D., and Grounds R.M. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth 88 5 (2002) 669-675
15. Ickeringill M., Shehabi Y., Adamson H., et al. Dexmedetomidine infusion without loading dose in surgical patients requiring mechanical ventilation: haemodynamic effects and efficacy. Anaesth Intensive Care 32 6 (2004) 741-745
16. Videira R.L., and Ferreira R.M. Dexmedetomidine and asystole. Anesthesiology 101 6 (2004) 1479 [author reply: 1479-80]
17. Chang N.S., Simone A.F., and Schultheis L.W. From the FDA: what's in a Label? A guide for the anesthesia practitioner. Anesthesiology 103 1 (2005) 179-185
18. Neubert A., Dormann H., Weiss J., et al. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf 27 13 (2004) 1059-1067
19. Conroy S., Choonara I., Impicciatore P., et al. Survey of unlicensed and off label drug use in paediatric wards in European countries: European Network for Drug Investigation in Children. BMJ 320 7227 (2000) 79-82
20. Choonara I. Unlicensed and off-label drug use in children: implications for safety. Expert Opin Drug Saf 3 2 (2004) 81-83
21. Wong I., Sweis D., Cope J., et al. Paediatric medicines research in the UK: how to move forward?. Drug Saf 26 8 (2003) 529-537
22. Baker R. FDA proposes new rules for off-label use of prescription drugs. Food and Drug Administration. BETA July (1998) 8-9
23. Hill P. Off license and off label prescribing in children: litigation fears for physicians. Arch Dis Child 90 Suppl 1 (2005) i17-i18
24. Tobias J.D., and Berkenbosch J.W. Initial experience with dexmedetomidine in paediatric-aged patients. Paediatr Anaesth 12 2 (2002) 171-175
25. Riker R.R., and Fraser G.L. Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit. Pharmacotherapy 25 5 Pt 2 (2005) 8S-18S
26. Esmaoglu A., Mizrak A., Akin A., et al. Addition of dexmedetomidine to lidocaine for intravenous regional anaesthesia. Eur J Anaesthesiol 22 6 (2005) 447-451
27. Avitsian R., Li J., Jain U., et al. Dexmedetomidine and awake fiberoptic intubation for possible cervical spine myelopathy: a clinical series. J Neurosurg Anesthesiol 17 2 (2005) 97-99
28. Talke P., Chen R., Thomas B., et al. Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery: the Study of Perioperative Ischemia Research Group. Anesthesiology 82 (1995) 620-633
29. Talke P., Chen R., Thomas B., et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg 90 (2000) 834-839
30. Wahlander S., Frumento R.J., Wagener G., et al. A prospective, double-blind, randomized, placebo-controlled study of dexmedetomidine as an adjunct to epidural analgesia after thoracic surgery. J Cardiothorac Vasc Anesth 19 5 (2005) 630-635
31. Mack P.F., Perrine K., Kobylanz E., et al. Dexmedetomidine and neurocognitive testing in awake craniotomy. J Neurosurg Anesthesiol 16 1 (2004) 20-25
32. Zornow M.H., Maze M., Dyek J.B., et al. Dexmedetomidine decreases cerebral blood flow velocity in humans. J Cereb Blood Flow Metab 13 (1993) 350-353
33. Thornton C., Lucas M.A., Newton D.E., et al. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. II: Auditory and somatosensory evoked responses. Br J Anaesth 83 3 (1999) 381-386
34. Tobias J.D., Berkenbosch J.W., and Russo P. Additional experience with dexmedetomidine in pediatric patients. South Med J 96 9 (2003) 871-875
35. Ferrari L.R., and Bedford R.F. General anesthesia prior to treatment of anterior mediastinal masses in pediatric cancer patients. Anesthesiology 72 6 (1990) 991-995
36. Eastwood P.R., Platt P.R., Shepherd K., et al. Collapsibility of the upper airway at different concentrations of propofol anesthesia. Anesthesiology 103 3 (2005) 470-477
37. Levanen J., Makela M.L., and Scheinin H. Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium. Anesthesiology 82 5 (1995) 1117-1125
38. Nichols D.P., Berkenbosch J.W., and Tobias J.D. Rescue sedation with dexmedetomidine for diagnostic imaging: a preliminary report. Paediatr Anaesth 15 3 (2005) 199-203
39. Koroglu A., Demirbileks S., Teksan H., et al. Sedative, haemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: preliminary results. Br J Anaesth 94 6 (2005) 821-824
40. Dasta J.F., Kane-Gill S.L., and Durtschi A.J. Comparing dexmedetomidine prescribing patterns and safety in the naturalistic setting versus published data. Ann Pharmacother 38 7-8 (2004) 1130-1135
41. Bloor B.C., Ward D.S., Belleville J.P., et al. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 77 6 (1992) 1134-1142
42. Dutta S., Lal R., Karol M.D., et al. Influence of cardiac output on dexmedetomidine pharmacokinetics. J Pharm Sci 89 4 (2000) 519-527
43. Venn M., Newman J., and Grounds M. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med 29 2 (2003) 201-207
44. Ramsay M.A., and Luterman D.L. Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology 101 3 (2004) 787-790
45. Tobias J.D., and Berkenbosch J.W. Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. South Med J 97 5 (2004) 451-455
46. Multz A.S. Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal. Anesth Analg 96 4 (2003) 1054-1055
47. Berkenbosch J.W., Tobias J.D., and Wankum P.C. Prospective evaluation of dexmedetomidine for noninvasive procedural sedation in children. Pediatric Critical Care Medicine 6 4 (2005) 435-439
48. Scheinin H., Aantaa R., Anttila M., et al. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers. Anesthesiology 89 3 (1998) 574-584
49. Berkenbosch J.W., and Tobias J.D. Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin. Pediatr Crit Care Med 4 2 (2003) 203-205